6 Einträge gefunden

1. Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients

   1. Bellon, Eugen
   2. Grupp, Katharina
   3. Ghadban, Tarik
   4. Tachezy, Michael
   5. Bachmann, Kai
   6. Izbicki, Jakob Robert
   7. Simon, Ronald

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC)

   1. Clauditz, Till Sebastian
   2. von Rheinbaben, Kirsten
   3. Lebok, Patrick
   4. Minner, Sarah
   5. Tachezy, Michael
   6. Borgmann, Kerstin
   7. Knecht, Rainald

   2014 - Forschungsinformationssystem des UKE
3. ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients

   1. Tachezy, Michael
   2. Harms-Effenberger, Katharina
   3. Zander, Hilke
   4. Minner, Sarah Jane Pauline
   5. Gebauer, Florian
   6. Vashist, Yogesh
   7. Sauter, Guido

   2012 - Forschungsinformationssystem des UKE
4. Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.

   1. Minner, Sarah Jane Pauline
   2. Kraetzig, Franziska
   3. Tachezy, Michael
   4. Kilic, Ergün
   5. Graefen, Markus
   6. Wilczak, Waldemar
   7. Bokemeyer, Carsten

   2011 - Forschungsinformationssystem des UKE
5. Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.

   1. Gebauer, Florian
   2. Tachezy, Michael
   3. Harms-Effenberger, Katharina
   4. von Loga, Katharina
   5. Zander, Hilke
   6. Marx, Andreas
   7. Kaifi, Jussuf

   2011 - Forschungsinformationssystem des UKE
6. ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.

   1. Tachezy, Michael
   2. Zander, Hilke
   3. Marx, Andreas H
   4. Gebauer, Florian
   5. Rawnaq, Tamina
   6. Kaifi, Jussuf T
   7. Sauter, Guido

   2011 - Forschungsinformationssystem des UKE